Solving Medical Mysteries in the World of Rar...

Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current state of clinical AI and what it takes to deploy AI systems in real-world healthcare settings. While much of the recent attention around AI has focused on copilots, chatbots, and ...  Show more

Nicolás Abad, founder and CEO of Telepatía, joins a16z to discuss building AI-powered tools for healthcare in Latin America. Inspired by the loss of his father to a preventable medical error, Adbad set out to address one of the region’s most significant challenges: a shortage of ...  Show more

A computer scientist fascinated by the genetic code and its application to rare disease, Rudy Benfredj moved into healthtech and cofounded Mendelian. Mendelscan, their core technology helps identify patients at risk of developing a rare disease early. We touch on the patient’s ...

Physician-scientist Anna Greka investigates the world's rarest genetic diseases, decoding the secrets of our cells through "molecular detective work." She explains how her team is using new, advanced technology to solve decades-old medical mysteries — and shows how this work coul ...  Show more

Physician-scientist Anna Greka investigates the world's rarest genetic diseases, decoding the secrets of our cells through "molecular detective work." This week we're revisiting her talk which explains how her team is using new, advanced technology to solve decades-old medical my ...  Show more

Physician-scientist Anna Greka investigates the world's rarest genetic diseases, decoding the secrets of our cells through "molecular detective work." She explains how her team is using new, advanced technology to solve decades-old medical mysteries — and shows how this work coul ...  Show more